Invitrogen Earns Ameristar® Award for GIBCO® Cell Culture Bottle Design
News Mar 02, 2009
Invitrogen, a division of Life Technologies, has announced that it has received the AmeriStar® Package Award from the Institute of Packaging Professionals for its new GIBCO cell culture bottle.
Invitrogen launched the redesigned GIBCO bottle in October of last year to offer scientists improved ease of use, efficient storage and reduced sample contamination for cell culture experiments.
The bottle is the result of three years of collaborative research and development; that involved testing more than 30 prototypes; between Invitrogen, global design consultancy IDEO and container manufacturer Graham Packaging Plastics, which helped develop the manufacturing plan for the innovative bottle design. The end result was a redesigned bottle that provides improved ergonomics for “under-the-hood” workflow, superior handling and storage, easier identification and additional space for supplements.
“This honor recognizes our corporate commitment to customer-driven innovation,” said Todd Laird, Vice President and General Manager of the Invitrogen Cell Culture Essentials business unit. “After extensive observation of scientists conducting cell culture workflow experiments, our team developed a new solution that resulted in a true breakthrough in user-centric design, transforming the way scientists work.”
AmeriStar evaluated more than 100 packages in 15 different categories, with the GIBCO bottle receiving honors in the medical device category. A formal awards ceremony will take place on May the 19th, as part of the IoPP Annual Packaging Summit in Chicago.
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE